Correlation Between Nuvalent and Dyne Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Dyne Therapeutics, you can compare the effects of market volatilities on Nuvalent and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Dyne Therapeutics.

Diversification Opportunities for Nuvalent and Dyne Therapeutics

NuvalentDyneDiversified AwayNuvalentDyneDiversified Away100%
0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Nuvalent and Dyne is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of Nuvalent i.e., Nuvalent and Dyne Therapeutics go up and down completely randomly.

Pair Corralation between Nuvalent and Dyne Therapeutics

Given the investment horizon of 90 days Nuvalent is expected to generate 0.69 times more return on investment than Dyne Therapeutics. However, Nuvalent is 1.46 times less risky than Dyne Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Dyne Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  2,787  in Nuvalent on December 12, 2024 and sell it today you would earn a total of  4,238  from holding Nuvalent or generate 152.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Nuvalent  vs.  Dyne Therapeutics

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -50-40-30-20-100
JavaScript chart by amCharts 3.21.15NUVL DYN
       Timeline  
Nuvalent 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Nuvalent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar65707580859095
Dyne Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar152025

Nuvalent and Dyne Therapeutics Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-4.48-3.35-2.23-1.12-0.01560.921.862.793.73 0.020.030.040.050.06
JavaScript chart by amCharts 3.21.15NUVL DYN
       Returns  

Pair Trading with Nuvalent and Dyne Therapeutics

The main advantage of trading using opposite Nuvalent and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.
The idea behind Nuvalent and Dyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio